Fondaparinux Market Trends, Research Report, Growth, Opportunities, Forecast 2022-2028

Orion Market Research Fondaparinux Market Report 2022: By Key Players, Trends, Size, Share and Forecast 2022-2028 Request a sample of our report on Fondaparinux Market: https://www.omrglobal.com/requestsample/fondaparinux-market

-----------------------------------------------------------------------------------Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404

The global fondaparinux market is estimated to grow at a CAGR of nearly 7.5% during the forecast period. Significant rise in the prevalence of arthritis is primarily driving the global fondaparinux market.

As per the Centers for Disease Control and Prevention (CDC), by 2040, the number of adults aged 18 years and over in the US with doctor-diagnosed arthritis is estimated to rise 49% to 78.4 million (25.9% of the estimated total US adult population), compared to 54.4 million adults in 2013–2015. Additionally, as per the Versus Arthritis, in UK, musculoskeletal conditions including arthritis and back pain affected nearly 18.8 million people in 2017.

A full report of Fondaparinux Market is available at: https://www.omrglobal.com/industryreports/fondaparinux-market Osteoarthritis is the most common form of arthritis that are affecting millions of people globally.

Globally, over 200 million women suffer from osteoporosis. 1 in 3 postmenopausal women has osteoporosis, which increases with age. Therefore, increasing prevalence of geriatric population is also a major cause for the rising incidences of osteoarthritis. As per the United Nations (UN), by 2050, 1 in 6

people globally will be more than the age of 65, increased from 1 in 11 in 2019. In 2019, 703 million people were aged 65 years or over globally, which is expected to double to 1.5 billion in 2050.

To learn more about this report request a sample copy @ https://www.omrglobal.com/requestsample/fondaparinux-market Osteoporosis commonly affects joints in hips, knees, spine, and hands, which results in the increasing number of hip and knee replacements. As per the Canadian Institute for Health Information (CIHI), in 2017-2018, 70,502 knee replacements and 58,492 hip replacements were performed in Canada. This shows a rise of 17.0% and 17.4%, respectively, over the last 5 years. According to the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man (NJR), there were a total of 242,629 cases registered to NJR during 2016/2017. It has shown a significant rise of over 20,000 joint replacement procedures than the previous year. This, in turn, is contributing to the adoption of fondaparinux to prevent deep vein thrombosis (blood clot) after the procedure.

Fondaparinux is used for the treatment of severe blood clots in the lungs or legs. It is often utilizing with another blood thinner drugs (warfarin). If blood clots are untreated, it can travel to the brain, heart, or lungs, causing serious breathing problems, stroke, or heart attack. Fondaparinux is further used for the prevention of blood clots after some procedures with an increased risk of blood clots, including knee and hip replacements, abdominal surgery, and hip fracture. Fondaparinux works similarly like heparin that blocks the activity of some clotting substances in the blood. However, fondaparinux has a longer half-life than heparin and does not interact with platelets. This, in turn, is contributing to the growth of the global fondaparinux market.

Global Fondaparinux Market- Segmentation

By Product Type  

Branded Generics

Fondaparinux Market– Segment by Region North America  

United States Canada

Europe      

Germany United Kingdom France Spain Italy Rest of Europe

Asia-Pacific    

China Japan India Rest of Asia-Pacific

Rest of the World  

Middle East & Africa Latin America

Company Profiles         

Apicore LLC Aurobindo Pharma Ltd. Cadila Healthcare Ltd. (CHL) Dr Reddy’s Laboratories Ltd. GlaxoSmithKline plc Italfarmaco S.p.A. Mylan N.V. Sandoz International GmbH ScinoPharm Taiwan, Ltd.

Reasons to Buying From us – 1.

2.

3.

4.

We cover more than 15 major industries, further segmented into more than 90 sectors.

More than 120 countries are for analysis.

Over 100+ paid data sources mined for investigation.

Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: anurag@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404